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Streblus asper Lour is a small tree found in tropical countries, such as India, Sri Lanka, Malaysia, the
Philippines and Thailand. Various parts of this plant are used in Ayurveda and other folk medicines
for the treatment of different ailments such as filariasis, leprosy, toothache, diarrhea, dysentery and
cancer. Research carried out using different in vitro and in vivo techniques of biological evaluation sup-
port most of these claims. This review presents the botany, chemistry, traditional uses and pharmacology
of this medicinal plant.
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Introduction
Streblus asper Lour (Family: Moraceae) is a small tree (Fig. 1)
which is indigenous to tropical countries such as India,
Sri Lanka, Malaysia, the Philippines and Thailand. It is known
by various names, e.g. Bar-inka, Berrikka, Rudi, Sheora, Koi,
Siamese rough bush and Tooth brush tree (1). In India it is
known by its several vernacular names, the most commonly
used ones being Shakhotaka (Sanskrit), Siora (Hindi), Sheora
(Bengali) and Piray (Tamil) (2). It is used traditionally in
leprosy, piles, diarrhea, dysentery, elephantiasis (3) and cancer
(4). It is a rigid shrub or gnarled tree; branchlets tomentose
or pubescent. Leaves are 2–4 inch, rigid, elliptic, rhomboid,
ovate or obovate, irregularly toothed; petiole 1/12 inch. Male
heads globose, solitary or 2-nate, sometimes androgynous;
peduncle short scabrid, flowers minute. Female flowers longer
peduncled. Fruit pisiform; perianth yellow. It is found in the
drier parts of India, from Rohilkund, eastward and southwards
to Travancore, Penang and the Andaman Islands (5).
The pharmacognostical studies of its stem bark as well
as its root bark have been carried out (6,7). It finds place in
the Ayurvedic Pharmacopoeia of India (8) and has also been
described in some monographs (9), but none have described
the complete chemistry and pharmacology of this important
ethnomedicinal plant. Therefore, we aimed to compile an
up-to-date and comprehensive review of S. asper that covers
its traditional and folk medicinal uses, phytochemistry and
pharmacology.
Ethnomedicinal/Traditional Uses
Streblus asper is a well known ethnomedicinal plant which is
also used in Ayurveda (2,10–14). Its use in the Indian tradi-
tional folk medicine is also well documented. Table 1 gives
the various traditional uses of different parts of this species
and the sources of information.
Phytochemistry
Streblus asper is a rich source of cardiac glycosides.
Reichstein and co-workers (15–18) have isolated more than
20 cardiac glycosides from the root bark of S. asper and were
able to structurally characterize  15 such compounds, mainly
as a result of the application of degradative techniques,
namely kamloside, asperoside, strebloside, indroside, canno-
dimemoside, strophalloside, strophanolloside, 16-O-acetyl-
glucogitomethoside, glucogitodimethoside, glucokamloside,
sarmethoside and glucostrebloside. The other glycosides
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furanosyl-O-a-l-rhamnopyranosyl-O-b-d-glucopyranoside
(19), lupanol-3-O-b-d-glucopyranosyl-[1-5]-O-b-d-xylofura-
noside (20) and vijaloside, i.e. periplogenin-3-O-b-d-gluco-
pyranosyl-[1-5]-O-b-d-xylopyranoside (21).
From the stem bark of this plant, a-amyrin acetate, lupeol
acetate, b-sitosterol, a-amyrin, lupeol and diol (22), streblo-
side and mansonin (23) have been isolated. A pregnane glycos-
ide named sioraside (24) has also been isolated. n-Triacontane,
tetraiacontan-3-one, b-sitosterol, stigmasterol, betulin and
oleanolic acid were identified from the aerial parts (25). An
unidentified cardenolide (26), b-sitosterol, a-amyrin and
lupeol were isolated from root bark and leaves (27). Figure 2
gives the structures of a few biologically active compounds
that have been isolated from S. asper.
The volatile oil (28) from fresh leaves of S. asper was
obtained in 0.005% yield as a brown liquid. The major con-
stituents of the volatile oil were phytol (45.1%), a-farnesene
(6.4%), trans-farnesyl acetate (5.8%), caryophyllene (4.9%)
and trans-trans-a-farnesene (2.0%). The other constituents
were a-copaene, b-elemene, caryophyllene, geranyl
acetone, germacrene, d-cadinene, caryophyllene oxide and
8-heptadecene.
Pharmacological Properties
Several workers have reported the different biological
activities of S. asper in various in vitro and in vivo test models.
Different parts of this plant have been found to exhibit car-
diotonic, antifilarial, anticancer, antimicrobial, anti-allergic
and antimalarial activities. These have been described in
greater detail in the following.
Cardiotonic Activity
The total ethanolic extract of the root bark of S. asper was
found to indicate interesting activity on blood pressure, iso-
lated frog heart, isolated rabbit intestine and guinea pig uterus.
An ab-unsaturated lactone was isolated which when adminis-
tered by i.v. route gave the LD50 of 4.8 mg kg
 1 in white mice.
Studies on isolated frog heart showed that it induces a positive
ionoptropic effect in 10
 5 dilution and a systolic response
in 10
 4 dilution. Pronounced in vitro spasmodic effect of
the compound was seen on the smooth muscles of the rabbit
intestine and guinea pig uterus in those high dilutions (14).
Pharmacological studies carried out have indicated that the
drug has got definite action on myocardium (29).
Antifilarial Activity
The crude aqueous extract of the stem bark of S. asper revealed
significant macrofilaricidal activity against Litomosoides
carinii and Brugia malayi in rodents. The study revealed two
cardiac glycosides, asperoside and strebloside, of the extract
to be responsible forantifilarial activity.Of the two glycosides,
the more effective macrofilaricide was asperoside which was
active at 50 mg kg
 1 orally against L. carinii in cotton rats
Figure 1. S. asper.( A) Whole tree. (B) Flowering twig.
Table 1. Ethnomedicinal uses of different parts of S. asper
S. no. Plant part Traditional uses Sources
1 Root As an application to unhealthy ulcers
and sinuses and as antidote to snake
bite (2), in epilepsy and obesity (10)
(2,10)
2 Stem Toothache (11) (11)
3 Stem bark Given in fever, dysentery and diar-
rhea (2,10), stomachache and urinary
complaints (11), useful in piles,
edema and wounds (10), decoction
effective against lymphadema,
chylurea and other effects of
filariasis (10,12,13)
(2,10–13)
4 Leaves Eye complaints (11) (11)
5 Milky juice/latex Antiseptic, astringent, applied to
chapped hands and sore feet (2), in
pneumonia and swells of cheek (11)
(2,11)
6 Fruit Eye complaints (11) (11)
7 Seeds Epistaxis and diarrhea (14) (14)
8 Part not specified Cancer, cholera, colic, diarrhea




218 Streblus asper Lour. (Shakhotaka)(>90%), B. malayi in mastomys (>70%) and Acanthocheil-
onema viteae in mastomys natalensis (>70%). The glycosides
were also active in vitro against all the three filarial species.
Significantly weak activity was detected in glycon and aglycon
portions of the parent glycosides (asperoside and strebloside).
Several cardiac glycosides of other origins did not show any
comparable antifilarial efficacy. The aglycosidic portion of
the extract, however, showed poor adulticidal activity (44.5%
activity at 1 g kg
 1 against L. carinii) (30). Streblus asper has
been used in the preparation of a few formulations also.
Shakhotaka Ghana Vati prepared from its stem bark was found
to be useful in filariasis (31). Besides this, another safe and
effective filaricide from the stem bark of S. asper, ‘Filacid’
has also been reported. A series of extraneous investigations
involving hundreds of patients infested with filarial parasites
have also established its efficacy against filariasis (32).
The effect of aqueous and alcoholic extract of S. asper was
also studied on the spontaneous movements of the whole
worm and nerve-muscle preparation of Setaria cervi, the
bovine filarial parasite, and on the survival of microfilariae
in vitro. Aqueous as well as alcoholic extract caused inhibition
of spontaneous motility of the whole worm and the nerve-
muscle preparation of S. cervi characterized by decreased
tone, amplitude and rate of contractions. The concentration
required to inhibit the movements of the nerve-muscle pre-
paration was l/25 for aqueous and l/160 for alcoholic extract
suggesting a cuticular permeability barrrier. The stimulatory
response of acetylcholine was blocked by alcoholic and not
by aqueous extract of S. asper. Both alcoholic as well as aque-
ous extracts caused death of microfilariae in vitro,L C 50 and
LC90 being 90 and 33.5 ng ml
 1, respectively (33). The in vitro
effects of asperoside and strebloside on S. cervi females were
also studied. Both asperoside and strebloside caused death
of the worms within 2–3 h at concentrations of 10 g ml
 1
(1.7 pmol) and were found to inhibit motility and glucose
uptake of the parasites at lower concentrations (0.1 g ml
 1;
0.17 pmol). These glycosides also inhibited the incorporation
of [U-14] C-glucose into macromolecules of S. cervi females.
Parasites preincubated with either asperoside and strebloside
had lowered profiles of glucokinase (EC 2.7.1.2), malate
dehydrogenase (EC 1.1.1.37) and succinate dehydrogenase
(EC 1.3.99.1) activities, suggesting that the lethal effects of
the glycosides were owing to effects on glucose metabolism
(34). It was found that asperoside and strebloside interfere
with the glutathione metabolism of the adult S. cervi, which
cause disturbance in various vital activities of the parasites
that ultimately results in the death of the parasites (35).
A preliminary study of S. asper (shakhotak) as an antilym-
phoedematous agent was carried out by Baranwal et al. (36).
Anticancer Activity
Streblus asper has been reported to possess anticancer activity
(37). KB cytotoxicity was found to be concentrated sequen-
tially in the methanol and dichloromethane extracts of S. asper
stem bark. Two cytotoxic cardiac glycosides, strebloside and
mansonin, were isolated which displayed significant activity
in KB cell culture system with ED50 values of 0.035 and
0.042 mgm l
 1, respectively. An isolate is considered to be
active in this system if it shows an ED50 of  4 mgm l
 1 (23).
The volatile oil from fresh leaves of S. asper showed
significant anticancer activity (ED50   30 mgm l
 1) from
cytotoxicity primary screening tests with P388 (mouse
lymphocytic leukemia) cells but no significant antioxidant
activity (IC50 values   100 mgm l



















































Figure 2. Structures of the biologically active compounds isolated from
S. asper.
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Different studies were carried out to determine the antimicro-
bial potential of leaves of S. asper (38–44). Ethanol extracts
from the sticks and leaves of S. asper have been shown to
inhibit the growth of Streptococcus mutans (38).
For Oral Hygiene
Studies demonstrated the antimicrobial activity of S. asper leaf
extract upon various microorganisms involving oral and
nasopharyngeal infections, especially S. mutans. Bactericidal
activity was found in the 50% ethanol (v/v) extract of S. asper
leaves. The extract possessed a selective bactericidal activity
towards Streptococcus, especially to S. mutans which has
been shown to be strongly associated with dental caries. The
extract had no effect on cultures of Escherichia coli, Staphylo-
coccus aureus and Pseudomonas aeruginosa, Staphylococcus
coagulase positive, Staphylococcus coagulase negative,
Serratia marcescens, Klebsiella pneumoniae, Enterobacter,
P. aeruginosa, Burkholderia pseudomeallei and Candida
albicans. The minimum growth inhibitory concentration and
the minimum bactericidal concentration of S. asper extract
against 10
8 CFU per ml of S. mutans was 2 mg ml
 1 (39).
In vitro study was carried out to determine the effects of a
sublethal concentration of S. asper leaf ethanolic extract on
adherence of C. albicans to human buccal epithelial cells
(HBEC). The findings indicated that the sublethal concentra-
tion of this extract may modulate candidal colonization of
the oral mucosa thereby suppressing the invasive potential of
the pathogen (40). An in vivo one group time series design
and single blind study was carried out to determine the antimi-
crobial effectiveness of a mouthrinse containing S. asper leaf
extract on S. mutans and total salivary bacteria following
single 60 s rinse. The results concluded that the mouthrinse
containing S. asper leaf extract can reduce S. mutans without
changing an oral ecology (41). Streblus asper extract solution
at 0.5% concentration (w/v) was investigated for inhibitory
effect on adherence of S. mutans on glass surfaces. However,
it did not show significant inhibitory effect on bacterial
adherence to glass surfaces (42). A single blind and crossover
design study was also carried out to study the effect of the
mouthrinse containing S. asper leaf extract on gingivitis and
plaque formation (43). The results revealed that when used in
mouthrinse the S. asper leaf extract significantly effected
only the gingival health. It reduced the gingival index but no
significant effect was seen on plaque growth.
Against Anaerobic Bacteria
In vitro study was also carried out to determine the anti-
bacterial effects of leaf extract of koi (S. asper) against the
following six anaerobic bacteria: Porphyromonas gingivalis
W50, Prevotella intermedia, Actinomyces naeslundii (T14V),
Peptostreptococcus micros, Actinobacillus actinomycetem-
comitans ATCC 43717 and ATCC 43718 (44). It was demon-
strated that 15 ml of the leaf extract at 250 and 500 mg ml
 1
had inhibitory effects towards all bacterial strains tested except
A. actinomycetemcomitans ATCC 43717. The extract had no
bactericidal activity against P. intermedia and A. naeslundii
(T14V). Although the extract did not show inhibitory effect
towards A. actinomycetemcomitans ATCC 43717 by disc
diffusion method, but it did inhibit growth of A. actino-
mycetemcomitans ATCC 43717 by using broth microdilution
method.
Anti-allergic Activity
Streblus asper showed promising anti-allergic activity in
experimental models. Anti-PCA (passive cutaneous anaphy-
laxis) and mast cell stabilizing activity of S. asper were inves-
tigated in mice and rats. Disodium cromoglycate (DSCG) was
used as standard anti-allergic drug. Streblus asper (50–100 mg
kg
 1, p.o.) in mice showed 60–74% anti-PCA activity. In rats
it showed dose-dependent (50–200 mg kg
 1, p.o.) anti-PCA
activity (56–85%). The mast cell stabilizing activity in rats
(10 mg kg
 1, p.o. · 4 days) showed 62% protection against
comp. 48/80 induced degranulation. In egg albumin induced
degranulation in sensitized rats there was 67% protection
with S. asper. These results were comparable with that of
DSCG (50 mg kg
 1, i.p.) (45).
Insecticidal Activity
Insecticidal effects have been shown in extracts of the
S. asper stem (46). Extracts from the stem bark of S. asper pos-
sess insecticidal activity against the fifth instar of Dysdercus
cingulatus. Methanolic extract showed an LC50 value of
5.56 mg per insect. Partition with chloroform increased the
insecticidal activity (LC50 2.01 mg per insect). Three poly-
phenolic rich fractions were obtained from silica gel column
chromatography of the chloroform fraction and found to
have noteworthy insecticidal activity (LC50: 1.82, 2.70 and
2.26 mg per insect) by topical application. This may provide
a useful beginning for the development of biopesticides (47).
Antiparasitic
In vitro antitrypanosomal activity of aqueous extract of leaves
of S. asper was studied at 5, 50, 500 and 1000 mg ml
 1 (48).
However, it did not show any significant activity and was
thus not taken up for in vivo studies.
Das and Beuria (49) have studied the antimalarial property
of the extract of S. asper in murine malaria. Giving the stem
bark extract of S. asper intraperitoneally has been shown to
stimulate a host immune response against Plasmodium berghei
in mice.
Summary and Conclusion
Streblus asper is a well-known plant used in the Indian System
of Medicine. In Ayurveda, the use of S. asper stem bark
is recommended against elephantiasis for which there is no
220 Streblus asper Lour. (Shakhotaka)effective cure in the modern system of medicine. Besides this,
folklore medicine also claims its use in cancer, ulcer, diarrhea,
dysentery, toothache, etc. Research carried out using different
in vitro and in vivo techniques of biological evaluation support
most of these claims.
Filariasis,adiseaseofconsiderablepublichealthimportance,
is a vector-borne helminthic infection occurring in tropical
and subtropical regions of the world. Diethylcarbamazine
(DEC) and ivermectin, the drugs used commonly for filariasis
are insufficient because of their inadequate effect on the adult
parasites. The high antifilarial activity of asperoside derived
from the stem bark of S. asper against L. carinii, Brugia malayi
and A. viteae in their respective hosts is unique as for the first
time a cardiac glycoside has exhibited antifilarial activity.
However, since the active antifilarial compounds are cardiac
glycosides, they are sure to produce cardiotoxicity and thus
it is necessary to dissociate the two activities. Attempts in
this direction were made by the authors (50) by subjecting
strebloside and asperoside to hydrogenation so as to reduce
the a–b unsaturated lactone ring. The results showed that at
a dose of 50 mg kg
 1 orally, although there was a decrease
in the macrofilaricidal activity exhibited by dihydroasperoside
as well as dihydrostrebloside, but there was a marked absence
of cardiotonic activity as compared to the parent compounds.
Also the dihydro derivatives affected the reproductive ability
of the female worms as they were found to be sterilized. A
fraction, ‘Streblofil’, containing these two dihydro compounds
was also prepared which also exhibited macrofilaricidal action
as well as sterilized the female worms (51,52). Asperoside
and strebloside were also found to be effective against S. cervi,
the bovine filarial parasite. These studies give credance to the
ethnomedicinal claims of S. asper being an antifilarial agent.
The branch of S. asper has been used as a tooth brush for
strengthening teeth and gums (53). Studies have also proven
that it exhibits selective bactericidal activity towards Strepto-
coccus, especially to S. mutans which has been shown to be
strongly associated with dental caries. Streblus asper extract
thus has the potential for being used as a natural product for
controlling dental caries. The anticancer principles have been
identified as strebloside and mansonin. Besides, the volatile
oil from the fresh leaves has also shown significant anti-
cancer activity. Studies have shown that S. asper possesses
cardiotonic, antimalarial, anti-allergic antitrypanosomal as
well as insecticidal properties. It is, therefore, in itself a very
important ethnomedicinal plant whose potential is yet to be
scientifically exploited.
Presently there is an increasing interest worldwide in
herbal medicines accompanied by increased laboratory invest-
igation into the pharmacological properties of the bioactive
ingredients and their ability to treat various diseases (54–56).
Numerous drugs have entered the international market through
exploration of ethnopharmacology and traditional medicine.
Although scientific studies have been done on a large
number of Indian botanicals, a considerably smaller number
of marketable drugs or phytochemical entities have entered
the evidence-based therapeutics. Efforts are therefore needed
to establish and validate evidence regarding safety and practice
of Ayurvedic medicines (57).
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